HDAC9 and breast carcinoma: As HDAC inhibitors are being developed for treatment of breast cancer acting through multiple epigenetic pathways, and numerous clinical trials are underway,21, 22, 23, 24 it is not surprising that FTY720 has such potent anticancer activity.